Albert B. Sabin Vaccine Institute,
Inc. (The)
Dba Sabin Vaccine Institute

CAGE Code: 5MPW2

NCAGE Code: 5MPW2

Status: Active

Type: Commercial Supplier

Dun & Bradstreet (DUNS): 849900175

CAGE 5MPW2 Albert B. Sabin Vaccine Institute, Inc. (The) Dba Sabin Vaccine Institute
CAGE 5MPW2 Albert B. Sabin Vaccine Institute,

Summary

Albert B. Sabin Vaccine Institute,, Inc. (The), Dba Sabin Vaccine Institute is an Active Commercial Supplier with the Cage Code 5MPW2 and is tracked by Dun & Bradstreet under DUNS Number 849900175..

Address

2000 Pennsylvania Ave Nw Ste 7000
Washington DC 20006-1921
United States

Points of Contact

Albert B. Sabin Vaccine Institute, http://www.sabin.org/

Related Information

DUNS Report

Associated CAGE Codes People who viewed this 'CAGE Code' also viewed...

Allen And Associates Intl Ltd Embassy Of The Republic Of Armenia Cromartie Construction Co Gallant Inc Ehrenkrantz And Eckstut Architects Higgins Art Services Llc Blumenthal Henry S Co Nassau Machine Products Co Tsunami Hair Studio Llc Progressive Office, Inc. Alliance For Redesigning Government Four Phase Systems Inc Police Executive Research Forum Affordable Supply Co Inc W.I.N.N. Group The Mid-Atlantic Telcom Plus L L C Louis Berger Group, Inc., The The Louis Berger Group, Inc Star Office Products Inc Wanda Avila

CAGE Code FAQ Frequently Asked Questions (FAQ) for CAGE 5MPW2

What is CAGE Code 5MPW2?
5MPW2 is the unique identifier used by NATO Organizations to reference the physical entity known as Albert B. Sabin Vaccine Institute, Inc. (The) Dba Sabin Vaccine Institute located at 2000 Pennsylvania Ave Nw Ste 7000, Washington DC 20006-1921, United States.
Who is CAGE Code 5MPW2?
5MPW2 refers to Albert B. Sabin Vaccine Institute, Inc. (The) Dba Sabin Vaccine Institute located at 2000 Pennsylvania Ave Nw Ste 7000, Washington DC 20006-1921, United States.
Where is CAGE Code 5MPW2 Located?
CAGE Code 5MPW2 is located in Washington, DC, USA.

Contracting History for CAGE 5MPW2 Contracting History for CAGE 5MPW2 Most Recent 25 Records

75A50123C00010
The Scope Of The Proposed Program Includes Manufacture Of Sabin?S Sudan Ebolavirus Vaccine (Bulk Drug Substance (Bds) And Final Drug Product (Fdp)) To Provide Doses That May Be Used In The Event Of An Outbreak Scenario. The Proposed Effort Will Utili
2 Aug 2023
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$71,390,114.00
75A50123C00010
The Scope Of The Proposed Program Includes Manufacture Of Sabin?S Sudan Ebolavirus Vaccine (Bulk Drug Substance (Bds) And Final Drug Product (Fdp)) To Provide Doses That May Be Used In The Event Of An Outbreak Scenario. The Proposed Effort Will Utili
8 Sep 2023
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$71,390,114.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
5 Oct 2022
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$98,624,151.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
27 May 2022
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$76,795,140.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
21 Mar 2022
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$76,332,505.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
14 Feb 2023
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$115,785,443.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
21 Dec 2021
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$75,113,142.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
4 May 2023
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$115,785,443.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
4 Nov 2021
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$75,113,142.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
18 Jan 2022
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$76,332,505.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
14 Feb 2023
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$115,785,443.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
23 Aug 2023
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$143,785,443.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
1 Sep 2021
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$75,113,142.00
75A50119C00055
Advance The Development Of Monovalent Vaccines For Prevention Of Marburg Virus (Marv) And Sudan Ebolavirus (Sudv) Disease.
21 Oct 2022
Barda - Aspr / Daappo / Barda Dcma
Department Of Health And Human Services (Hhs)
$114,125,182.00